2006
DOI: 10.1002/bmc.648
|View full text |Cite
|
Sign up to set email alerts
|

Purification and characterization of a high specificity polyclonal antibody to the adenomatous polyposis coli tumour suppressor protein

Abstract: Recombinant proteins, commonly expressed in fusion with an affinity tag to facilitate purification, are often used as immunogens for polyclonal antibody production. Careful immunopurification of the antibody product is often the key to obtaining a high-specificity polyclonal antibody against the protein domain of interest. This study describes the purification and characterization of such an antibody directed against the adenomatous polyposis coli (APC) tumour suppressor. We used a combination of affinity chro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…The following antibodies were used: anti-APC (APC2, produced in our laboratory (Catimel et al, 2006)), anti-APC (H290; Santa Cruz, Santa Cruz, CA, USA), anti-CK1a (Santa Cruz), anti-axin-1 (Zymed, San Francisco, CA, USA), anti-phospho-b-catenin (Cell Signaling, Danvers, MA, USA, 9561, pS33, pS37, pT41 and 9565, pT41, pS45), anti-b-catenin (19920/610153; BD Transduction Laboratories, San Jose, CA, USA), anti-GSK3b (G22320; BD Transduction Laboratories), anti-actin (clone AC-40; Sigma, St Louis, MS, USA), anti-btubulin (clone 2.1; Sigma) and anti-HA (262K#2362; Cell Signaling). To generate C-terminally tagged APC-GFP, enhanced GFP was subcloned as a BamH1/Not1 fragment into pEF-mycAPC (Faux et al, 2004) after removing the STOP.…”
Section: Antibodies and Plasmidsmentioning
confidence: 99%
“…The following antibodies were used: anti-APC (APC2, produced in our laboratory (Catimel et al, 2006)), anti-APC (H290; Santa Cruz, Santa Cruz, CA, USA), anti-CK1a (Santa Cruz), anti-axin-1 (Zymed, San Francisco, CA, USA), anti-phospho-b-catenin (Cell Signaling, Danvers, MA, USA, 9561, pS33, pS37, pT41 and 9565, pT41, pS45), anti-b-catenin (19920/610153; BD Transduction Laboratories, San Jose, CA, USA), anti-GSK3b (G22320; BD Transduction Laboratories), anti-actin (clone AC-40; Sigma, St Louis, MS, USA), anti-btubulin (clone 2.1; Sigma) and anti-HA (262K#2362; Cell Signaling). To generate C-terminally tagged APC-GFP, enhanced GFP was subcloned as a BamH1/Not1 fragment into pEF-mycAPC (Faux et al, 2004) after removing the STOP.…”
Section: Antibodies and Plasmidsmentioning
confidence: 99%
“…Immunopurified polyclonal anti-Phlda1 antibody was generated for use on mouse tissue (1). Briefly, antibody was purified from rabbit serum immunized with C-terminal Phlda1 peptide (LHSQPQGHRLLRSC) (Auspep) conjugated to maleimide-activated keyhole limpet hemocyanin (Pierce).…”
Section: Generation Of An Immunopurified Polyclonal Anti-phlda1 Antibodymentioning
confidence: 99%